Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Shoker

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 3, 2007
Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized studyD Rush, D Arlen, A Boucher, et al.
Transplantation Proceedings|September 1, 2009
Similar lipid profile but improved long-term outcomes with sirolimus after cyclosporine withdrawal compared to sirolimus with continuous cyclosporineJ M Morales, A Hartmann, R Walker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 15, 2018
A Multicenter Case-control Study of the Effect of Acute Rejection and Cytomegalovirus Infection on Pneumocystis Pneumonia in Solid Organ Transplant RecipientsS M Hosseini-Moghaddam, M Shokoohi, G Singh, et al.
Clinical Transplantation|June 1, 2000
Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokineticsM D Pescovitz, D Conti, J Dunn, et al.
Transplantation|December 27, 1996
A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients. Report of the Canadian Neoral Renal Transplantation Study GroupP Keown, D Landsberg, P Halloran, et al.
Transplantation|March 21, 1998
Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow-up in stable renal transplant recipients: a report of the Canadian Neoral Renal Study GroupE Cole, P Keown, D Landsberg, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 3, 2007
Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized studyD Rush, D Arlen, A Boucher, et al.
Transplantation Proceedings|September 1, 2009
Similar lipid profile but improved long-term outcomes with sirolimus after cyclosporine withdrawal compared to sirolimus with continuous cyclosporineJ M Morales, A Hartmann, R Walker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 15, 2018
A Multicenter Case-control Study of the Effect of Acute Rejection and Cytomegalovirus Infection on Pneumocystis Pneumonia in Solid Organ Transplant RecipientsS M Hosseini-Moghaddam, M Shokoohi, G Singh, et al.
Clinical Transplantation|June 1, 2000
Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokineticsM D Pescovitz, D Conti, J Dunn, et al.
Transplantation|December 27, 1996
A randomized, prospective multicenter pharmacoepidemiologic study of cyclosporine microemulsion in stable renal graft recipients. Report of the Canadian Neoral Renal Transplantation Study GroupP Keown, D Landsberg, P Halloran, et al.
Transplantation|March 21, 1998
Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow-up in stable renal transplant recipients: a report of the Canadian Neoral Renal Study GroupE Cole, P Keown, D Landsberg, et al.
Pageof 4